• Normally, COX-2 leads to the synthesis of pro-inflammatory prostanoids.
• Aspirin modifies the active site of COX-2. The modified COX-2 leads to synthesis of anti-inflammatory lipoxins rather than prostanoids.

(epi-LXA and LXA have different configurations of the 15-OH, but they both function as lipoxins)